Follow-up of Newborn Blood Screening

For the purposes of quality assurance, quality improvement and ongoing evaluation of the effectiveness of the Newborn Blood Screening Program, including the determination of those disorders and diseases that should be included in the Department's Newborn Blood Screening Program, the health care provider shall report to the Newborn Blood Screening Program, upon request, the following information as soon as possible but no later than 30 days after the request: (A) Diagnostic and long term outcomes for all newborns whose newborn screening results warranted diagnostic evaluation for a newborn screening disorder or disease; and (B) Any additional relevant information regarding these diagnostic and long term outcomes as specified by the Newborn Blood Screening Program.